Abstract Cells contain a large number of antioxidants to prevent or repair the damage caused by reactive oxygen species, as well as to regulate redox-sensitive signaling pathways
Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al
One analysis used medical and pharmacy claims data to evaluate outcomes in 371,698 patients with type 2 diabetes initiating GLP-1 RA, SGLT2i, DPP-4i and sulfonylurea class medications, with the primary outcome being time-to-treatment for DME or PDR
"Scientists have had a hard time getting this drug into the body where it didn't get broken down in the GI tract by the stomach acid," Egan said